Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: A prospective study

Gut

Volumn 45, Issue 4, 1999, Pages 484-488

  Lembo, T ^a,b   Ippoliti, A F ^a   Ramers, C ^a   Weinstein, W M ^a  

^a UCLA MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardia; Columnar epithelium; Gastro oesophageal reflux disease; Helicobacter pylori; Squamous epithelium; Z line

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTICLE; BIOPSY; CARDITIS; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GASTROESOPHAGEAL REFLUX; GOBLET CELL; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INTERMETHOD COMPARISON; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; PRIORITY JOURNAL; SCORING SYSTEM; SQUAMOUS EPITHELIUM;

EID: 0032857667     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.4.484     Document Type: Article

References (29)

1. Schindlbeck NE, Wiebecke B, Klauser AG, et al. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 1996;39:153-6.
2. Weinstein WM, Bogoch ER, Bowes KL. The normal human esophageal mucosa: a histological reappraisal. Gastroenterology 1975;68:10-4.
3. Cushieri A, Michel ME, Sadek S, et al. Computerized 24-hour ambulatory esophageal pH monitoring and esophagogastroduodenoscopy in the reflux patient. A comparative study. Ann Surg 1984;200:724-8.
4. Masclee AA, de Best AC, de Graaf R, et al. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol 1990;25:225-30.
5. Mattioli S, Pilotti V, Spangaro M, et al. Reliability of 24 hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1989;34:71-8.
6. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226:522-30.
7. Spechler SJ, Wang HH, Chen YY, et al. GERD versus H. pylori infections as potential causes of inflammation in the gastric cardia [abstract]. Gastroenterology 1997;112:A297.
8. Sherman R, Baig Z, Choudhry U, et al. The prevalence of specialized columnar epithelium in patients with symptoms and/or signs of gastroesophageal reflux. Gastrointest Endosc 1997;45:A232.
9. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998;114:633-9.
10. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-19.
11. Antonioli DA, Goldman H. Change in the type and location of gastric adenocarcinoma. Cancer 1982;50:775-81.
12. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
13. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis", and Barrett's esophagus, and sequelac of therapy. Am J Surg Pathol 1996;20:S31-50.
14. Schnell TG, Sontag SJ, Chejfed G. Adenocarcinomas arising in tongues of short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-43.
15. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
16. Weinstein WM. Precursor lesions for cancer of the cardia. Gastrointest Endosc Clin North Am 1997;7:19-28.
17. Castell DO. Normal values in esophageal manometry. In: Esophageal motility testing. 2nd edn. Norwalk, Connecticut: Appleton and Lange, 1994.
18. Johnson LF, DeMeester TR. Twenty-four hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325-30.
19. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastroesophageal junction. Lancet 1994;344:1533-6.
20. Johnston MH, Hammond AS, Laskin W, et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996;91:1507-11.
21. Blot WJ, Devesa SS, Fraumeni JFJ. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1993;270:1320
22. Meyers WC, Damiano RJ, Rotolo FS, et al. Adenocarcinoma of the stomach: changing patterns over the last 4 decades. Ann Surg 1987;105:1-8.
23. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-13.
24. Locke GR III, Talley NJ, Carpenter HA, et al. Changes in the site- and histology-specific incidence of gastric cancer during a 50 year period. Gastroenterology 1995;109:1750-6.
25. Wolf BC, Khettry U, Leonardi HK, et al. Benign lesions mimicking malignant tumors of the esophagus. Hum Pathol 1988;19:148-54.
26. Nandurkar S, Talley NJ, Martin CJ, et al. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997;40:710-15.
27. Clark GWB, Ireland AP, Chandrasoma P, et al. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction: a new marker for gastroesophageal reflux disease [abstract]. Gastroenterology 1994;106:A63.
28. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997;92:414-18.
29. Hirota HK, Loughney TM, Laza DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.